Authors: Arreaza, GA Sharif, S Cameron, MJ Chen, W Delovitch, TL

Citation: Ga. Arreaza et al., Role of regulatory T cells in the pathogenesis of autoimmune diabetes, CURR DIR AU, 4, 2001, pp. 308-332

Authors: Sharif, S Arreaza, GA Zucker, P Mi, QS Sharif, S Arreaza, GA Zucker, P Mi, QS Sondhi, J Naidenko, OV Kronenberg, M Koezuka, Y Delovitch, TL Gombert, JM Leite-De-Moraes, M Gouarin, C Zhu, R Hameg, A Nakayama, T Taniguchi, M Lepault, F Lehuen, A Bach, JF Herbelin, A

Citation: S. Sharif et al., Activation of natural killer T cells by alpha-galactosylceramide treatmentprevents the onset and recurrence of autoimmune Type 1 diabetes, NAT MED, 7(9), 2001, pp. 1057-1062

Authors: Cameron, MJ Strathdee, CA Holmes, KD Arreaza, GA Dekaban, GA Delovitch, TL

Citation: Mj. Cameron et al., Biolistic-mediated interleukin 4 gene transfer prevents the onset of type 1 diabetes, HUM GENE TH, 11(12), 2000, pp. 1647-1656

Authors: Cameron, MJ Arreaza, GA Waldhauser, L Gauldie, J Delovitch, TL

Citation: Mj. Cameron et al., Immunotherapy of spontaneous type I diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer, GENE THER, 7(21), 2000, pp. 1840-1846

Authors: Cameron, MJ Arreaza, GA Grattan, M Meagher, C Sharif, S Burdick, MD Strieter, RM Cook, DN Delovitch, TL

Citation: Mj. Cameron et al., Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes, J IMMUNOL, 165(2), 2000, pp. 1102-1110

Authors: Bergerot, I Arreaza, GA Cameron, MJ Burdick, MD Strieter, RM Chensue, SW Chakrabarti, S Delovitch, TL

Citation: I. Bergerot et al., Insulin B-chain reactive CD4(+) regulatory T-cells induced by oral insulintreatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells, DIABETES, 48(9), 1999, pp. 1720-1729